FDA Considers Restricting Tobacco Flavors, Including Menthol
Gottlieb blames PBM rebate tactics for weak biosimilar market.
U.S. FDA wants to let drugmakers test Alzheimer’s treatments on patients years before disease shows outward signs.
President Donald Trump won’t act on past threats to take drastic measures to lower prices.
Trump Budget Targets Pricey Drugs, Patient Out-of-Pocket Costs
Trump's CDC Director Steps Down Amid Tobacco Stock Scandal
Diarrhea Drug Imodium Swept Up in Opioid Crisis Under FDA Rules
High-Tech Tobacco Gadget Hits Snag in Push to Disrupt Smoking
Senate Confirms Former Drug Executive Azar as Health Secretary
FDA Staff Question If Philip Morris Technology Cuts Smoking Risk
Durbin said bipartisanship is “all we’ve asked for.”
Where's Mine? Workers Wonder If Trump Tax Cut Will Trickle Down
Trump Health Nominee Faces Another Grilling on U.S. Drug Costs
Plan to Slash U.S. Drug Costs Leans on Problem-Plagued Factories
Drugmaker Fresenius Warned Again for Ignoring Bad Quality Tests
This Indian drugmaker halted hundreds of tests after employees found potentially tainted products, USFDA says.
Children’s Health Insurance Gets Yet Another Patch in House Bill
A vote on extending a program that provides health insurance to low-income children will slide into 2018.
Obamacare Subsidy Lawsuit Settled by White House, Democrats
FDA Targets Insulin for Increased Competition to Lower Prices
Bipartisan Approach on Drug Prices Emerging After Health Fights